Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2019 Feb 20;14(2):e0212830. doi: 10.1371/journal.pone.0212830

Correction: The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study

Johannes Ehler, Axel Petzold, Matthias Wittstock, Stephan Kolbaske, Martin Gloger, Jörg Henschel, Amanda Heslegrave, Henrik Zetterberg, Michael P Lunn, Paulus S Rommer, Annette Grossmann, Tarek Sharshar, Georg Richter, Gabriele Nöldge-Schomburg, Martin Sauer
PMCID: PMC6382272  PMID: 30785958

In Fig 3, the headings above the graph are incorrectly swapped. The left heading should be “No Brain Dysfunction” and the right heading should be “Brain Dysfunction.” The authors have provided a corrected version here.

Fig 3. Longitudinal profile of plasma neurofilament light chain levels in 16 sepsis patients with brain dysfunction and four patients without brain dysfunction.

Fig 3

NfL levels significantly increased in patients with brain dysfunction over time which was not observed in patients without brain dysfunction. Bold line indicates the development of mean plasma neurofilament levels over time. NfL Neurofilament light.

Reference

  • 1.Ehler J, Petzold A, Wittstock M, Kolbaske S, Gloger M, Henschel J, et al. (2019) The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy–A prospective, pilot observational study. PLoS ONE 14(1): e0211184 10.1371/journal.pone.0211184 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES